EWTX
Edgewise Therapeutics, Inc. · Healthcare
General Counsel John R Moore sold $52K of Edgewise Therapeutics, Inc.
Sold$51,598
$10.91Price
4,730Shares
−61%Stake
What EWTX did after the filing
- The stock from Thu, Sep 8 close, $12.06
- −21.2%
- S&P 500, same days
- −8.4%
Measured over 30 trading days, to the Oct 20 close.
Traded Tue, Sep 6. Filed Thu, Sep 8, 12:16 PM ET, during the session. Returns use the Sep 8 close and the Oct 20 close. Not investment advice.